Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-15-248010
Filing Date
2015-07-08
Accepted
2015-07-08 16:42:00
Documents
1
Group Members
SV LIFE SCIENCES FUND V (GP), L.P.SV LIFE SCIENCES FUND V STRATEGIC PARTNERS, L.P.SV LIFE SCIENCES FUND V, L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D d93629dsc13d.htm SC 13D 104701
  Complete submission text file 0001193125-15-248010.txt   106466
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Subject) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88910 | Film No.: 15979602
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SV LIFE SCIENCES ADVISERS, LLC ONE BOSTON PLACE, SUITE 3900 BOSTON MA 02108
Business Address C/O SV LIFE SCIENCES ADVISERS, LLC ONE BOSTON PLACE, SUITE 3900 BOSTON MA 02108 617-367-8100
SVLSF V, LLC (Filed by) CIK: 0001644160 (see all company filings)

EIN.: 264430055 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D